Temperature changes, chills, hair shedding, sulfur burps, and low mood appear more often in user reports than in trial tables
Iron deficiency can manifest as fatigue that gets attributed to the medication itself, which is worth distinguishing from other causes
This effect is primarily mediated by two incretin hormones, namely glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)
The risk of underreacting could be serious
A review of GLP-1 receptor agonists: Evolution and advancement, through the lens of randomised controlled trials
Contact your GP or diabetes team if you experience persistent side effects, have concerns about your treatment, or if your blood glucose control deteriorates whilst using GLP-1 therapy